chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer reporting on herself. A female patient of an unspecified age and ethnicity received PREVNAR 13 at single dose on 06Nov2017 for pneumonia, immunisation. The patient medical history and concomitant medications were not reported. On 06Nov2017 an hour after the injection the patient experienced her arm swelled up, was hot and was sore about an hour after the injection. After a few days, the swelling went down, but it still hurt and was hot.
I felt a little queasy before going to bed on the 31st, but I was't surprised because I had a similar reaction to the first vaccine. I woke up sometime after 3 AM violently ill. I was extremely weak as I tried to get to the toilet to throw up. I could not throw up. I had chills and became shakier, took my fever. It was slightly over 100 degrees, which is a high temperature for me. I did not even run a temperature of note when I had pneumonia (which, by the way, I contracted within a week of the 1st shingles shot. I blamed the shot. I was able to drink a little water. I considered calling 911 since I live alone. Finally, I was able to doze off. I slept most of the next day.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications are provided.  No treatment medications are provided.
Had stroke in 2 weeks  and 2 days after receiving second shot and later learned that I apparently had a stroke following the first shot time period from cardiovascular physician/physician assistant.
Began experiencing strong heartbeat approx. every 2 seconds, self check with smart watch showed small beat between large beats.  Thought it could be just response to caffeine use..  Wife was going to visit family, waited until 01April to go to clinic, doctor sent me to emergency room.  EKG used indicated PVCs more than 50% of my heartbeats.
After the pt received the vaccine, he asked me for some water because he wasn't feeling very well. I didn't have any on hand, so I offered chocolate. When I came back he tried to reach for it, but was struggling. He dropped it and started making jerking movements and slumping over. I put my hand on his chest to keep him propped up and called for my technician. After a minute or so, he was responsive, but sweating and his skin tone became washed out. I told him he should lay on the floor and prop his feet up on the chair. He said that made him feel better. I got him some orange juice to drink after he got off the floor. He remained near the location for 30mins and then did some shopping to make sure he would be okay before leaving with his wife.
Fatigue, Muscle or body aches, Headaches, New loss of taste or smell, Congestion or runny nose and Diarrhea, chills, heaviness in chest at times
Information has been received from a nurse concerning one of two sisters (another sister's adverse event captured in WAES1105USA04010) who was vaccinated with GARDASIL. The nurse reported two sisters who wanted to be vaccinated simulatneuosly. She recollected that she and another nurse at both of the sisters on the same table, administered each sister a shot of GARDASIL at the same time, and she reported that both sisters lost consciousness at the same time. She reported she and another nurse held both of the sisters up to keep them from falling off the table, since they could not lay them down on the same table. She stated that this occurrence was over a year ago which was in approximately 2010, and that both sisters were "fine with no residual effects." Neither of the girls was injured in any way, but she stated that she would never do that again. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous prospective pregnancy report as received from a physician, via company representative, refers to a 16 year old female patient. On an unknown date the patient was vaccinated with GARDASIL (dose, lot number and route were not reported). Concomitant medications were not reported. According to the physician, the patient who received all three doses in the GARDASIL series, received an unspecified number of these doses during pregnancy. There was no adverse experience reported except for the pregnancy. The Last Menstrual Period (LMP) and Estimated date of deliver (EDD) was not know. The pregnancy outcome was unknown. Patient sought medical attention, spoke with the physician. Additional information has been requested.
Red itchy are site, predominantly post shot 2 weeks. Currently still itchy intermittently  6 weeks post shot pityraisis rosea appeared. On 6/21/2021. Today is 10/17/2021. Rash is still present and widespread. I have taken 1 course of vacyclover in August. Physician tells me nothing more can be done.
Mild pain since injection. At about day five post vaccine I had itching on the arm from shoulder to elbow (no rash). Day 7 a small rash appeared at injection site, continued itching. From day 7 the rash has increased in size each day, with continued itching. Itching is constant but increased in the early morning and late evening.
Able to stick a magnet to his arm; This spontaneous case was reported by a consumer and describes the occurrence of ILL-DEFINED DISORDER (Able to stick a magnet to his arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILL-DEFINED DISORDER (Able to stick a magnet to his arm). At the time of the report, ILL-DEFINED DISORDER (Able to stick a magnet to his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported.  The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: The follow-up was received on 9-JUN-2021 and has no new information.
(L) arm began to swell at site of immunization the day after it was given. The area continued to swell and became sore and tender to touch. Mom had marked the area w/ a ring around it the day after and when he was seen, it had doubled in size. Patient was prescribed KEFLEX, an antibiotic for 10 days.
I was exposed to Covid in November. I tested negative twice but had nerve pain along the right side of my face when my son had tested positive.  Both times I got the vaccination the nerve pain in my face came back.  It was fairly painful the second time. The concern is that I had an inflammatory response similar to when I actually may have had Covid both times.  It went away within 48 hours and I have been done since.
positive COVID test; positive COVID test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 27Oct2021 (Lot number: EW0217) at the age of 37 years as dose 3 (booster), single, intramuscular, administered in arm right, administration date 16Mar2021 (Lot number: EL3247) as dose 2, single and intramuscular, administered in arm right, administration date 23Feb2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU VACCINE VII taken for immunisation, administration date 27Oct2021. The patient had no known allergies. The patient had no other vaccine in 4 weeks and no other medications in two weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 02Jan2022 20:00, outcome "recovering" and all described as "positive COVID test". The event "positive covid test" and "positive covid test" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (05Jan2022) positive. Therapeutic measures were not taken as a result of vaccination failure, covid-19. The patient had no covid prior vaccination.
Near injection site of 1st dose of moderna covid-19 vaccine, left arm swollen, and small bruise . Red rash appeared about 10 days after injection.  The red rash was about 2.5  inches by 1.5 inches, and was itchy. The rash got  larger over the next 5 -6 days, but progressively less red and itchy .  Rash appears to be fading after 7 -8  days, but still mildly swollen area.
Left Upper Extremity Numbness Narrative: 15 minutes after vaccination developed Numbness and Tingling down his arm. Slowly resolving
rashes on her torso; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes on her torso) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced RASH (rashes on her torso). At the time of the report, RASH (rashes on her torso) outcome was unknown.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates the patients were vaccinated with improperly stored ROTATEQ (lot# L033693, expiration date 31-MAY-2017; Lot# L029617, expiration date 19-MAY-2017; Lot# M004890, expiration date 10-NOV-2017; dose was not reported) orally. The vaccines were exposed to 33 F for 3 hours and 49 F for 50 minutes without previous excursion. The issue was due to datealogger. No symptoms were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Localized itching and warmth at injection site developed in the first 10 minutes following injection. Patient was given diphenhydramine 100mg PO x 1 and monitoring continued. MD contacted, advised cold compresses, APAP/IBU prn. By 11:30, itching subsided, still warm. MD okay to send home, pt agreeable, will monitor and call MD if sx worsen.
tested positive for COVID-19 approximately 3 weeks after her second dose of COMIRNATY/Mild cold like symptoms; tested positive for COVID-19 approximately 3 weeks after her second dose of COMIRNATY/Mild cold like symptoms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 8 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2 (tris), single and (Batch/Lot number: unknown) as dose 1 (tris), single for covid-19 immunisation. Relevant medical history included: "asthma" (unspecified if ongoing); "other respiratory illnesses" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "tested positive for COVID-19 approximately 3 weeks after her second dose of COMIRNATY/Mild cold like symptoms". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Clinical course: The patient tested positive for COVID-19 approximately 3 weeks after her second dose of COMIRNATY. Mild cold like symptoms reported. Event took place after use of product. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
7 days after injection developed a irritating, burning, red rash 3" in diameter at injection site.
Around 11:30 pm I noticed patient had a rash on her face.  At midnight I noticed she was breathing weird and had a rapid heart beat. While nursing her at 12:30 she started moving weird which turned into spasms and convulsions.  I quickly stopped nursing her but she was lifeless and unresponsive she would open her eyes and then they would roll back in her head I couldn't get her to "wake up" the fever was 104 o called the on call dr who said "it wasnt a symptom from vaccines" she finally started responding a little more but was shaking so bad when reaching for toy she couldn't stop shaking enough to grab it. Episode lasted over 2 hours. Rapid heart rate and shallow breathing lasted hours.
had a virus; This is a spontaneous report from a contactable consumer (patient). A 63 years old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Apr2021 (Batch/Lot Number: EW0150) as single dose at right arm for covid-19 immunisation. Medical history was none. Concomitant medication(s) included amlodipine besilate for blood pressure abnormal. The patient reported that on 22Apr2021, he went to the emergency and they said he had a virus and he had appointment made there, so he want to know did he went there to take his second shot or what did he do next. Consumer stated that No Treatment receive, he was hydrated and they gave him through the bottles in the hospital and send him home the same day. The outcome of the event was unknown.
Pain slowly developed after injection and became severe by 12 he post injection. I iced my arm and took hydrocodone/acetaminophen (5-325), two doses, two hours apart at bedtime to help me sleep. It felt a little better in the morning but again, the pain progressed over the day to severe pain at bedtime, and only one dose of hydrocodone/acetaminophen was needed. Felt bruised the following day and has improved over the week.
Headache, chills, feeling very tired, muscle aches, nausea. Woke up shaking very hard and couldn't breathe much, was able to get breathing under control and stop the shaking.
Patient admitted to hospital on 16AUG21 with bilateral pulmonary emboli. Received dose #2 of Pfizer COVID vaccine on 09AUG21. No history of coagulation disorder or previous emboli
Pt vaccinated with Engerix-B developed diarrhea, fatigue, headache, joint aches extremities, nausea, adverse reaction to vaccine generalized body aches, epigastric cramping.
Dermatographia and welts, itchiness, redness on various parts of body, especially back of head/neck, hands, wrists
Same day post vax, this pt experienced 'right thigh pain, adverse drug reaction versus early cellulitis.' The pt experienced erythema at the injection site. an ER or physician visit was required. Follow-up information was received from a physician. The pt was administered Pediaprofen and cephalexin monohydrate (Keflex) and was sent home. Subsequently, the pt recovered. No further information is available.
67 year old patient received the flu vaccine not recommended for his age group. Patient received the flulaval quad for patients 6 months and up. Patient was observed for 15 minutes after receiving the vaccine. Patient tolerated the vaccine well, and patient was stable.
was in bed; chills; puked; This spontaneous case was reported by a nurse and describes the occurrence of BEDRIDDEN (was in bed), CHILLS (chills) and VOMITING (puked) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     It was reported that patient had no allergies. It was reported that patient has never been diagnosed or tested positive for COVID-19. No other vaccine was received by the patient within 1 month prior to Moderna COVID-19 vaccine.     On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced BEDRIDDEN (was in bed), CHILLS (chills) and VOMITING (puked). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, BEDRIDDEN (was in bed), CHILLS (chills) and VOMITING (puked) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs were not reported.  Symptoms lasted for one day.   This case was linked to US-MODERNATX, INC.-MOD-2022-598091 (E2B Linked Report). This case was linked to MOD-2022-598089, MOD-2022-598068 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-598091:same reporter
My nasal passages, throat, and bronchial tubes started to swell up; feeling faint; general malaise; My nasal passages, throat, and bronchial tubes started to swell up; My nasal passages, throat, and bronchial tubes started to swell up; brain fog; This is a spontaneous report from a non-contactable consumer (patient).  A 62-years-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 08Apr2021 14:00 (Batch/Lot Number: ER8729) (at the age of 62-years-old) as single dose for covid-19 immunization.  Medical history included known allergies: penicillin from an unknown date. The patient's concomitant medications were not reported. Historical Vaccine included BNT162B2, dose 1, administered in arm left on 18Mar2021 01:45 P.M. (Batch/Lot Number: ER2613) (at the age of 62-years-old) for covid-19 immunization. The patient did not get COVID prior vaccination and did not receive COVID test post vaccination. About five minutes (as reported) after the patient received the shot, she started feeling faint on 08Apr2021 02:15 P.M. Her nasal passages, throat, and bronchial tubes started to swell up on 08Apr2021 02:15 P.M. Taking a decongestant when she got home helped that. For a few days she had congestion and brain fog along with general malaise. Treatment received included she took decongestants. The outcome of the events was resolved in Apr2021.  No follow-up attempts are possible. No further information is expected.
c/o itching & raised, erythematous rash on neck & chest that is spreading to face; called MD; poss rash infected;
This spontaneous report as received from a pharmacist refers to an unknown number of patients. It was reported that improperly stored doses of ZOSTAVAX (lot # and expiration date were not provided), that were transported in dry ice, were administered subcutaneously to an unspecified number of patients in a one time dose of 0.65 ml. No adverse effects were reported. No further information was provided. Additional information has been requested.
Electrical shocks in brain Brain fog Difficutly breathing Shortness of breath Elevated blood pressure Heart raising Weak legs  Severe muscle and joint pain Organ pain Abnormal labs Extrmeme dehydration Extreme weight gain (26 lbs in 3 months)
Rash started in abdominal area and spread over the entire body.   Nasal Congestion.  Used Zyrtec 7.5 mg nightly for following week.  Used Aveeno oatmeal bath.
Increased swelling, tenderness left upper arm 4-5-5cm Tx for localized cellulitis with cephalexin 250mg tid x 5 days.
Had fever of 102, devel transient rash that spread over body & went away no sooner then they came-was eventually unable to raise arms & lt leg w//joint pains; pt was taken to MD on 6APR92 @ 10AM; given meds; pt adm to hosp & tests done;
Pt recvd 3 doses of Heptavax 8MAR85, 10APR85 & 29SEP85 & 1 dose of Engerix-B 10JUN90 for Hep B; 13SEP91 titer was found to be neg; 30JAN92 recvd booster dose;
kicking of legs, red face, poss trouble breathing, afterwards was tired & pale; no tx sought I phoned nurse & MD who did not think it was related; 5 days later an allergy test showed poss allergy to eggs;
Diarrhea; stomach cramping; nausea; fatigue; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 12:00 PM at single dose in left arm for COVID-19 immunisation. The patient was vaccinated at hospital. Patient age at vaccination was 35 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included hypothyroid, known allergy to milk and latex, and COVID-19 on an unspecified date.  Concomitant medications included levothyroxine sodium (LEVOTHYROXINE SODIUM), escitalopram oxalate (LEXAPRO), montelukast sodium (SINGULAIR). On 23Jan2021 at 12:00 pm, the patient experienced diarrhea, stomach cramping, nausea, fatigue. No treatment was given for the events. The events were resolving. The patient was not tested for COVID-19 post vaccination.  No follow-up attempts are possible; Information about Lot/Batch number cannot be obtained.
VACCINES ADMINISTERED BY NURSE, RN. HER REPORT WAS AS FOLLOWS: PT PASSED OUT SHORTLY AFTER VACCINE ADMINISTRATION, APPROXIMATELY 2 MINUTES AFTER. SCRAPED CHIN WHEN SHE FELL. PLACED PT ON GROUND AND ELEVATED FEET ON CHAIR. CAME TO AFTER ABOUT 5 SECONDS. ENCOURAGED FLUIDS, REST. NO C/O DIZZINESS & NORMAL HR WHEN LEAVING. PATIENT SAID SHE FELT DIZZY RIGHT BEFORE PASSING OUT. MOM IS A PHARMACIST, TALKED WITH HER ABOUT WHEN TO CALL DOC IF CONCERNED ABOUT PATIENT.
patient got sick; Initial information was received on 09-Nov-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional (patient).  This case involves patient [age and gender unspecified] who got sick (illness), while patient received vaccine INFLUENZA VACCINE [Flu shot].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported ] via an unknown route at an unknown administration site prophylactic vaccination.  On an unknown date, the patient developed a non-serious patient got sick (illness) unknown latency following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.